Answers are grounded in this paper and cite their sources.
Background The pentose-phosphate pathway (PPP) plays a vital role in cell growth and metabolic reprogramming. However, its role in human cancer remains unclear. Methods We conducted a systematic analysis to investigate the complex and crucial roles of the PPP using multi-omics data from more than 10,000 samples across 33 cancer types sourced from multiple databases, including the Molecular Signature Databases, The Cancer Genome Atlas, and Cancer Single-cell State Atlas. Independent cohorts such as IMvigor210 and Liver Cancer-RIKEN, Japan Project from International Cancer Genome Consortium (ICGC-LIRI-JP). Results PPP-related genes were upregulated in most cancers, a phenomenon possibly driven by copy number variation and DNA methylation. Single-cell analysis revealed significant tumor-promoting features of PPP. We developed a PPP activity score to quantify the overall expression of PPP-related genes. PPP activity scores were significantly correlated with multiple hallmark pathways, the tumor microenvironment, cancer stemness, and immune-related signatures. Drug analysis revealed that high PPP activity scores contributed to resistance to drug-targeting pathways, including PI3K/mTOR, RTK, and TP53 signaling. In addition, PPP activity scores are potential predictors of immunotherapy outcomes. Prognostic analysis revealed that whereas individual PPP-related genes had varying effects on survival, high PPP activity scores were generally associated with poor prognosis, particularly in liver cancer. Conclusions This study underscores the critical molecular and clinical roles of the PPP in human cancers and highlights its potential as a promising target for cancer treatment.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: